3,005
Views
48
CrossRef citations to date
0
Altmetric
Commentary

Cytokines and COVID-19: friends or foes?

, & , MD, PhDORCID Icon
Pages 2363-2365 | Received 21 May 2020, Accepted 17 Jul 2020, Published online: 25 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Parmida Sadat Pezeshki & Nima Rezaei. (2021) Immune checkpoint inhibition in COVID-19: risks and benefits. Expert Opinion on Biological Therapy 21:9, pages 1173-1179.
Read now

Articles from other publishers (47)

Sheryar Afzal, Aimi Syamima Abdul Manap, Ali Attiq, Ibrahim Albokhadaim, Mahmoud Kandeel & Sameer M. Alhojaily. (2023) From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Frontiers in Pharmacology 14.
Crossref
Miguel Angel Pardiño-Vega & Norma Estela Herrera-González. (2023) Loss of regulation of T helper 17 cells: a definitive factor for critical cases of coronavirus disease 2019. Exploration of Immunology, pages 490-499.
Crossref
Alakesh Das, Surajit Pathak, Madhavi Premkumar, Chitra Veena Sarpparajan, Esther Raichel Balaji, Asim K. Duttaroy & Antara Banerjee. (2023) A brief overview of SARS-CoV-2 infection and its management strategies: a recent update. Molecular and Cellular Biochemistry.
Crossref
Mikhael Haruo Fernandes de Lima, Caio Cavalcante Machado, Daniele Carvalho Nascimento, Camila Meirelles S. Silva, Juliana Escher Toller-Kawahisa, Tamara Silva Rodrigues, Flavio Protassio Veras, Marjorie Cornejo Pontelli, Italo A. Castro, Dario Simões Zamboni, José-Carlos A. Filho, Thiago M. Cunha, Eurico Arruda, Larissa Dias da Cunha, Renê D. R. Oliveira, Fernando Q. Cunha & Paulo Louzada-Junior. (2023) The TIGIT+ T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation. Scientific Reports 13:1.
Crossref
Nikoo Saeedi, Narjes Sadat Farizani Gohari, Amir Ali Moodi Ghalibaf, Ali Dehghan & Mohammad Bagher Owlia. (2023) COVID-19 infection: a possible induction factor for development of autoimmune diseases?. Immunologic Research 71:4, pages 547-553.
Crossref
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Maisra M. El-Bouseary, Rabab S. Hamad, Mahmoud Abdelhamid & Gaber El-Saber Batiha. (2023) The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review. Journal of Immunology Research 2023, pages 1-14.
Crossref
Adrhyan Araújo, Gabriella Sgorlon, Letícia Ereira Aguiar, Matheus Henrique Monteiro Cavalcante Cidrão, Karolaine Santos Teixeira, Juan Miguel Villalobos Salcedo, Ana Maísa Passos-Silva & Deusilene Vieira. (2023) Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19. Experimental Biology and Medicine 248:9, pages 787-797.
Crossref
Mohammed Alrouji, Hayder M. Al‐Kuraishy, Ali I. Al‐Gareeb, Heba Elhadad, Athanasios Alexiou, Marios Papadakis, Hanan A. Ogaly, Ahmed M. Elgazzar & Gaber El‐Saber Batiha. (2023) Immunological interactions in helminths‐SARS CoV ‐2 coinfection: Could old enemy be a friend today? . Parasite Immunology 45:5.
Crossref
Anila Khalique, Mawieh Hamad & Jalal Taneera. (2023) Short-term exposure to interleukin-6 does not affect angiotensin-converting enzyme 2 expression in human pancreatic islets. Advances in Biomedical and Health Sciences 2:4, pages 190-191.
Crossref
Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, Mazin A. A. Najm, Guzal N. Sobirova, Zarnigor O. Bafoyeva, Ahmed Taifi, Ola Kamal A. Alkadir, Yasser Fakri Mustafa, Rasoul Mirzaei & Sajad Karampoor. (2022) The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update. Journal of Medical Virology 94:11, pages 5128-5148.
Crossref
Mohsen Rokni, Mohammad Sarhadi, Milad  Heidari Nia, Leila Mohamed Khosroshahi, Somaye Asghari, Saman Sargazi, Shekoufeh Mirinejad & Ramin Saravani. (2022) Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R , and IL6 genes are associated with COVID‐19 risk and severity in an Iranian population . Cell Biology International 46:7, pages 1109-1127.
Crossref
Soheila Montazersaheb, Seyed Mahdi Hosseiniyan Khatibi, Mohammad Saeid Hejazi, Vahideh Tarhriz, Afsaneh Farjami, Faramarz Ghasemian Sorbeni, Raheleh Farahzadi & Tohid Ghasemnejad. (2022) COVID-19 infection: an overview on cytokine storm and related interventions. Virology Journal 19:1.
Crossref
Paulina Niedźwiedzka-Rystwej, Adam Majchrzak, Sara Kurkowska, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz & Miłosz Parczewski. (2022) Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. International Journal of Molecular Sciences 23:9, pages 4545.
Crossref
Milad Heidari Nia, Mohsen Rokni, Shekoufeh Mirinejad, Maryam Kargar, Sara Rahdar, Saman Sargazi, Mohammad Sarhadi & Ramin Saravani. (2021) Association of polymorphisms in tumor necrosis factors with SARS‐CoV‐2 infection and mortality rate: A case‐control study and in silico analyses. Journal of Medical Virology 94:4, pages 1502-1512.
Crossref
Mohammad A. Al-Mterin, Alhasan Alsalman & Eyad Elkord. (2022) Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients. Frontiers in Immunology 13.
Crossref
Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lu, Ming Wang, Lin Zhu, Junjian Hu, Tingting Liu, Ke Ma, Meifang Han & Xiaoping Luo. (2022) The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduction and Targeted Therapy 7:1.
Crossref
Nihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, Birnur Sinem Karaoğlan, Khalid Shah & Gürkan Öztürk. (2022) Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives. Cells 11:3, pages 465.
Crossref
Masoomeh Dadkhah, Sahand Talei, Donya Doostkamel, Soheila Molaei & Nima Rezaei. (2022) The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review. Reviews in the Neurosciences 33:1, pages 79-92.
Crossref
Seyed A. Nejadghaderi, Amene Saghazadeh & Nima Rezaei. (2021) Health Care Policies and COVID-19 Prevalence: Is There Any Association?. International Journal of Health Services 52:1, pages 9-22.
Crossref
Yauhen Statsenko, Tetiana Habuza, Tatsiana Talako, Tetiana Kurbatova, Gillian Lylian Simiyu, Darya Smetanina, Juana Sido, Dana Sharif Qandil, Sarah Meribout, Juri G. Gelovani, Klaus Neidl-Van Gorkom, Taleb M. Almansoori, Fatmah Al Zahmi, Tom Loney, Anthony Bedson, Nerissa Naidoo, Alireza Dehdashtian, Milos Ljubisavljevic, Jamal Al Koteesh & Karuna M. Das. (2022) Reliability of Machine Learning in Eliminating Data Redundancy of Radiomics and Reflecting Pathophysiology in COVID-19 Pneumonia: Impact of CT Reconstruction Kernels on Accuracy. IEEE Access 10, pages 120901-120921.
Crossref
Fatemeh Sodeifian, Mahsa Nikfarjam, Naghmeh Kian, Kawthar Mohamed & Nima Rezaei. (2021) The role of type I interferon in the treatment of COVID‐19. Journal of Medical Virology 94:1, pages 63-81.
Crossref
Nihayet Bayraktar, Hamdiye Turan, Mehmet Bayraktar, Ali Ozturk & Hamza Erdoğdu. (2021) Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐19. Journal of Medical Virology 94:1, pages 154-160.
Crossref
Md Sadique Hussain, Parvarish Sharma, Daljeet Singh Dhanjal, Navneet Khurana, Manish Vyas, Neha Sharma, Meenu Mehta, Murtaza M. Tambuwala, Saurabh Satija, Sukhwinder Singh Sohal, Brian.G.G. Oliver & Hari S. Sharma. (2021) Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases. Chemico-Biological Interactions 348, pages 109637.
Crossref
Saman Sargazi, Roghayeh Sheervalilou, Mohsen Rokni, Milad Shirvaliloo, Omolbanin Shahraki & Nima Rezaei. (2021) The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets. Cell Biology International 45:8, pages 1599-1612.
Crossref
Huakan Zhao, Lei Wu, Guifang Yan, Yu Chen, Mingyue Zhou, Yongzhong Wu & Yongsheng Li. (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduction and Targeted Therapy 6:1.
Crossref
Homa Pourriyahi, Amene Saghazadeh & Nima Rezaei. (2021) Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. Journal of Neuroimmunology 356, pages 577578.
Crossref
Mona Mirbeyk, Amene Saghazadeh & Nima Rezaei. (2021) A systematic review of pregnant women with COVID-19 and their neonates. Archives of Gynecology and Obstetrics 304:1, pages 5-38.
Crossref
Masoud Etemadifar, Nahad Sedaghat, Ali Aghababaee, Parisa K Kargaran, Mohammad Reza Maracy, Mazdak Ganjalikhani-Hakemi, Milad Rayani, Amir Parsa Abhari, Reza Khorvash, Mehri Salari & Hosein Nouri. (2021) COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?. Multiple Sclerosis and Related Disorders 51, pages 102915.
Crossref
Ramin Lotfi, Rasoul Nasiri Kalmarzi & Seyed Askar Roghani. (2021) A review on the immune responses against novel emerging coronavirus (SARS-CoV-2). Immunologic Research 69:3, pages 213-224.
Crossref
Helene F. Rosenberg & Paul S. Foster. (2021) Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies. Seminars in Immunopathology 43:3, pages 383-392.
Crossref
Amene Saghazadeh & Nima Rezaei. (2021) Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19. Emergent Materials 4:1, pages 293-312.
Crossref
Amene Saghazadeh & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 119 147 .
Negar Moradian, Marjan Moallemian, Farnaz Delavari, Constantine Sedikides, Carlos A. CamargoJrJr, Pedro J. Torres, Armin Sorooshian, Saeid Paktinat Mehdiabadi, Juan J. Nieto, Stephane Bordas, Hamid Ahmadieh, Mohammad Abdollahi, Michael R. Hamblin, Frank W. Sellke, Jack Cuzick, Bozkurt Biykem, Michael Schreiber, Babak Eshrati, Georg Perry, Ali Montazeri, Ali Akbar Saboury, Roya Kelishadi, Amirhossein Sahebkar, Ali A. Moosavi-Movahed, Hassan Vatandoost, Mofid Gorji-Bandpy, Bahram Mobasher & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 923 936 .
Sara Momtazmanesh, Noosha Samieefar, Lucina Q. Uddin, Timo Ulrichs, Roya Kelishadi, Vasili Roudenok, Elif Karakoc-Aydiner, Deepak B. Salunke, Jan L. Nouwen, Juan Carlos Aldave Becerra, Duarte Nuno Vieira, Ekaterini Goudouris, Mahnaz Jamee, Morteza Abdullatif Khafaie, Morteza Shamsizadeh, Mohammad Rasoul Golabchi, Alireza Samimiat, Donya Doostkamel, Alireza Afshar, Mohammad Amin Khazeei Tabari, Melika Lotfi, Reza Yari Boroujeni, Niloofar Rambod, Anzhela Stashchak, Alla Volokha, Dainius Pavalkis, André Pereira, Amir Hamzah Abdul Latiff, Rauf Baylarov, Bagher Amirheidari, Mojtaba Hedayati Ch, Antonio Condino-Neto & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 911 921 .
Kawthar Mohamed, Rangarirai Makuku, Eduardo Rodríguez-Román, Aram Pascal Abu Hejleh, Musa Joya, Mariya Ivanovska, Sara A. Makka, Md Shahidul Islam, Nesrine Radwan, Attig-Bahar Faten, Chunfeng Xiao, Leander Marquez & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 891 910 .
Zahra Kolahchi, Manlio De Domenico, Lucina Q. Uddin, Valentina Cauda, Igor Grossmann, Lucas Lacasa, Giulia Grancini, Morteza Mahmoudi & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 825 837 .
Sara Hanaei, Farnam Mohebi, Maziar Moradi-Lakeh, Parnian Jabbari, Surinder Kumar Mehta, Liudmyla S. Kryvenko, Livio Luongo, Loďc Dupré & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 61 79 .
Helia Mojtabavi, Nasirudin Javidi, Anne-Frédérique Naviaux, Pascal Janne, Maximilien Gourdin, Mahsa Mohammadpour, Amene Saghazadeh & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 687 703 .
Shirin Moossavi, Kelsey Fehr, Hassan Maleki, Simin Seyedpour, Mahdis Keshavarz-Fathi, Farhad Tabasi, Mehrdad Heravi, Rayka Sharifian, Golnaz Shafiei, Negin Badihian, Roya Kelishadi, Shahrzad Nematollahi, Majid Almasi, Saskia Popescu, Mahsa Keshavarz-Fathi & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 575 604 .
Marjan Moallemian Isfahani, Zahra Emam-Djomeh, Idupulapati M. Rao & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 485 497 .
Bahareh Gholami, Samira Gholami, Amir Hossein Loghman, Behzad Khodaei, Simin Seyedpour, Nasrin Seyedpour, Amene Saghazadeh & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 369 402 .
Ali Nowroozi, Sepideh Razi, Kamal Kant Sahu, Fabio Grizzi, Jann Arends, Mahsa Keshavarz-Fathi & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 315 331 .
Maryam Fotouhi, Elham Samami, Sahar Mohseni, Amir Nasrollahizadeh, Mohammad Haddadi, Mona Mirbeyk, Amene Saghazadeh & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 293 313 .
Mahsa Eskian & Nima Rezaei. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 179 196 .
Nima Rezaei, Saboura Ashkevarian, Mahsa Keshavarz Fathi, Sara Hanaei, Zahra Kolahchi, Seyedeh-Sanam Ladi Seyedian, Elham Rayzan, Mojdeh Sarzaeim, Aida Vahed, Kawthar Mohamed, Sarah Momtazmanesh, Negar Moradian, Zahra Rahimi Pirkoohi, Noosha Sameeifar, Mahsa Yousefpour, Sepideh Sargoli, Saina Adiban, Aida Vahed, Niloufar Yazdanpanah, Heliya Ziaei & Amene Saghazadeh. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19 1 22 .
Mohsen Rokni, Kazem Ahmadikia, Somaye Asghari, Shahabodin Mashaei & Fahimeh Hassanali. (2020) Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness. BMC Infectious Diseases 20:1.
Crossref
Muhammad Asif. (2020) Coronavirus (COVID-19) Symptoms, Treatment, and Recent Medical Challenges to the World: A Review. Khalij-Libya Journal of Dental and Medical Research 4:2, pages 23-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.